The latest price target for Alignment Healthcare (NASDAQ:ALHC) was reported by UBS on May 1, 2026. The analyst firm set a price target for $22.00 expecting ALHC to rise to within 12 months (a possible 20.42% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Alignment Healthcare (NASDAQ:ALHC) was provided by UBS, and Alignment Healthcare maintained their neutral rating.

The last upgrade for Alignment Healthcare Inc happened on November 24, 2025 when JP Morgan raised their price target to $20. JP Morgan previously had a neutral for Alignment Healthcare Inc.

The last downgrade for Alignment Healthcare Inc happened on March 6, 2024 when Piper Sandler changed their price target from $12 to $6 for Alignment Healthcare Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alignment Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alignment Healthcare was filed on May 1, 2026 so you should expect the next rating to be made available sometime around May 1, 2027.

While ratings are subjective and will change, the latest Alignment Healthcare (ALHC) rating was a maintained with a price target of $21.00 to $22.00. The current price Alignment Healthcare (ALHC) is trading at is $18.27, which is out of the analyst’s predicted range.